Pictura Bio US, Inc.
StreetZero Signal 79
About Pictura Bio US, Inc.
Pictura Bio is a rapid pathogen detection company and spin-out from the University of Oxford. It combines single-molecule fluorescent microscopy with machine learning to identify pathogens in under a minute. The company develops rapid diagnostics tools for clinicians to determine causes of infection and provides laboratory-quality test results for infectious disease at the point of care.
LATEST FUNDINGPrivate Placement
$15.0M
Announced 2026-09-28
TOTAL RAISED$3.87M
IN THE NEWS
- 🔗 Pictura Bio Stock Price, Funding, Valuation, Revenue & Financial Statements
- 🔗 Our Companies - Ahren Innovation
- 🔗 Pictura Bio, one-minute diagnostics platform, PIC-ID.
- 🔗 PICTURA BIO LTD overview - Find and update company information - GOV.UK
- 🔗 PICTURA BIO LTD more information - Find and update company information - GOV.UK
EMPLOYEES—
FOUNDED2021
HQOxford, United Kingdom
Industry
Biotechnology
Tags
BiotechnologyDiagnosticsMachine LearningSpinout
Key highlights
- Spin-out from University of Oxford developing one-minute pathogen detection.
- Combines fluorescent microscopy and machine learning for open-question infection diagnostics.
- Focuses on point-of-care infectious disease testing to reduce wait times.
- Previously known as OXDX Ltd before rebranding in 2022.
Ask StreetZero about Pictura Bio US, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account